When was Shape Memory Medical founded?

Shape Memory Medical was founded in 2009 and raised its 1st funding round 6 years after it was founded.

Where is Shape Memory Medical located?

Shape Memory Medical is headquartered in Santa Clara, United States. It is registered at Santa Clara, California.

How many employees does Shape Memory Medical have?

As of Aug 31, 2026, the latest employee count at Shape Memory Medical is 50.

Is Shape Memory Medical a funded company?

Shape Memory Medical is a funded company, having raised a total of $99.9M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 15, 2015.

When was the latest funding round of Shape Memory Medical?

Shape Memory Medical's latest funding was a $***** Series C round on Jul 02, 2026, with participation from 1 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.1B in funding in 2026 to date.

Where does Shape Memory Medical rank among its competitors?

Shape Memory Medical ranks 1st amongst 20 active competitors, of which 10 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Shape Memory Medical, which secured $10M in Jul, 2026.

Who are the top competitors of Shape Memory Medical?

Shape Memory Medical's top competitors include Instylla, Transverse Medical and Innova Vascular. Among them, Shape Memory Medical secured the most recent funding round in July, 2026.

Shape Memory Medical - 2026 Company Profile, Team, Funding & Competitors

Company Details

Shape Memory Medical is a developer of embolization devices based on Shape Memory Polymer material. The company is developing peripheral vascular and neurovascular embolization devices. SMP foams are low-density polyurethane, and their formulation and pore sizes can be modified to create materials with a wide range of different properties.

Website: shapemem.com
Social
Email ID: *****@shapemem.com
Registered Address: Santa Clara, California

Key Metrics

Founded Year

2009

Location

Santa Clara, United States

Stage

Series C

Total Funding

$99.9M in 10 rounds

Latest Funding Round

Series C, Jul 02, 2026, $*****

Investors

Earlybird & 7 more

Ranked

1^st among 20 active competitors

Employee Count

50 as on Aug 31, 2026

Similar Companies

Instylla & 18 more

View Shape Memory Medical's full profile

Shape Memory Medical is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Shape Memory Medical Inc. CIN: 32038639004 , United States, Active	May 19, 2016	$1 - $1M (As on May 18, 2020)	-	-
DEP SHAPE MEMORY THERAPEUTICS, INC. CIN: 263929045 , United States, Active	Dec 31, 1999	-	58 (As on Dec 31, 2024)	-

Shape Memory Medical has raised a total funding of $99.9M over 10 rounds. Its first funding round was on Jan 15, 2015. Its latest funding round was a Series C round on Jul 02, 2026 for $*****. 1 investor participated in its latest round. Shape Memory Medical has 8 institutional investors.

Here is the list of recent funding rounds of Shape Memory Medical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 02, 2026	2138249	Series C	6526179	2920237	7285851	3297688
Apr 15, 2025	9764218	Series C	6515419	1088068	9819061	7442774
Feb 06, 2024	6599700	Series C	8123277	3531291	Earlybird	HBM Healthcare Investments & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Shape Memory Medical's funding rounds and investors

The founders of Shape Memory Medical is Duncan Maitland.

Here are the details of Shape Memory Medical's key team members:

Duncan Maitland: Co-Founder of Shape Memory Medical. They serve on the board of 1 company.
Contact Info: 1 email address

Shape Memory Medical's Board of Directors

Shape Memory Medical's board has 14 active members. Duncan Maitland, Michael Henson, Thomas Thaler, Thom Rasche, James Y Lancaster, Edward F. Ruppel, Jr, Jonathan Hartman, Carolyn M. Bruguera, Jim Gamett, James Y. Lancaster, Carla Kikken-Jussen, Edward Ruppel, Edward F. Ruppel, Jr. and Edward F. Ruppel are independent board members.

Here is the list of Shape Memory Medical's board of directors:

Name	Type	Representing	Status	Duration
Duncan Maitland	Independent board member	-	Current	11y 7m
dtvoens	Independent board member	-	Current	8y 1m
vuyamoq	Independent board member	-	Current	4y 7m
cktklzw	Independent board member	-	Current	5y 9m
iixpvul	Independent board member	-	Current	3y 8m
dnhieip	Independent board member	-	Current	5y 7m
unoq{o{	Independent board member	-	Current	2y 2m
cnmhkxj	Independent board member	-	Current	7y 9m
ymy{{vi	Independent board member	-	Current	7y 9m
jjwfte{	Independent board member	-	Current	8y 5m
vyhjqho	Independent board member	-	Current	4y 3m
kmqsqfj	Independent board member	-	Current	8y 5m
thjdzyu	Independent board member	-	Current	4y 8m
vhmxlvy	Independent board member	-	Current	2y 8m

View details of Shape Memory Medical's Founder profiles and Board Members

Shape Memory Medical's employee count trend

Shape Memory Medical has 50 employees as of Aug 26. Here is Shape Memory Medical's employee count trend over the years:

Employee count trend for Shape Memory Medical

Uncover Shape Memory Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Shape Memory Medical include Instylla, Transverse Medical and Innova Vascular. Here is the list of Top 10 competitors of Shape Memory Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Shape Memory Medical 2009, Santa Clara (United States), Series C	Developer of embolization devices based on Shape Memory Polymer material	$99.9M	Earlybird, Taiwania Capital & 6 others	58/100
2nd	Instylla 2017, United States, Series B	Developer of hydrogel technology for embolization therapy	$98.6M	Sparta Group, Delos Capital & 6 others	44/100
3rd	Transverse Medical 2011, Golden (United States), Series B	Developer of a device to prevent stroke during transcatheter aortic valve replacement heart procedures	$26.8M	Grant Park Ventures, Flight Partners Capital	40/100
4th	Innova Vascular 2018, Irvine (United States), Series A	Developer of medical device for the minimally invasive treatment of vascular disease	$21.9M	Black Diamond Ventures	39/100
5th	Fluidx Medical Technology 2015, Salt Lake City (United States), Series B	Developer of an embolic device to control vascular occlusion	$12M	MedMountain Ventures	38/100
6th	LaNua Medical 2024, Galway (Ireland), Seed	Developer of image-guided technologies for safe and effective endovascular embolization solutions	$6.3M	Elkstone, Atlantic Bridge & 2 others	36/100
7th	Hybernia Medical 2006, Uniondale (United States), Series A	Developer of solutions for acute ischemic stroke treatment	$3.71M	HHS	30/100
8th	aria 2017, San Diego (United States), Unfunded	Provider of pocket-sized pump device to manage lymphedema	-	-	29/100
9th	EnCompass F2 Carson City (United States), Series C	Developer of embolic filtration technology designed for cardiac procedures	$40.3M	-	28/100
10th	Vicora 2021, Buffalo (United States), Series A	Developer of a thrombectomy system utilizing integrated distal tip vibration	$3.4M	-	27/100